Latest news
2017 - Astrocytes - new target for CNS regeneration in stroke and ALS - Milos Pekny - University of Gothenburg
During human ageing and in diseases and injuries affecting the brain and spinal cord, such as stroke and ALS (amyotrophic lateral sclerosis), the...
2017 - Molecular mechanisms and new treatment strategies of type 2 diabetes - Margit Mahlapuu - University of Gothenburg
The prevalence of type 2 diabetes (T2D) is increasing dramatically and T2D has become one of the major global health threats. Intensive...
2017 - Development of antibody-based immunotherapy for Parkinson's disease - Martin Ingelsson - Uppsala University, Sweden
In Parkinson's disease, alpha-synuclein accumulates in the neurons of the brain and intermediate forms of this protein, called oligomers, are particularly harmful. We...
2017 - The brain's galanin and substance P systems are altered in depression: Opening for new treatment - Tomas Hökfelt - Karolinska Institutet
Depression is a life-threatening (suicide), common and costly disease (affecting 300 million people worldwide, costing an unimaginable €380 billion in...
2017 – Torsten Söderberg’s Academy Professorship in Medicine 2018 – Göran K. Hansson – Royal Swedish Academy of Sciences
The Torsten Söderberg Foundation currently funds six academic professorships in medicine (the most recent of which is currently being filled) at a level of 2 million...
2017 - Streptococcal modification of antibody glycosylation in severe infections - Mattias Collin - Lund University
Most proteins in our immune system are glycoproteins, with carbohydrates (glycans) influencing their function. Antibodies are central to our acquired immune system...
2016 - Novel Immune activation-based Drug Discovery Strategies for psychiatric disorders - Sophie Erhardt - Karolinska Institutet
Our project aims to identify biomarkers for psychiatric symptoms such as psychosis and suicidal ideation. The goal is to refine clinical...
2016 - Role of VEGF-B mediated lipotoxicity in diabetic complications - Ulf Eriksson - Karolinska Institutet
Type 2 diabetes is a major medical challenge with several hundred million patients worldwide. The disease is also rapidly increasing...
2016 - Lysozyme: A new treatment strategy for Alzheimer's disease - Ann-Christin Brorsson - Linköping University
My research team has recently discovered that the protein lysozyme may have a neuroprotective effect in Alzheimer's disease (AD). AD is characterized by...
2016 - Development of pairwise binding drugs - Ulf Landegren - Uppsala University, Sweden
Drug development is expensive and difficult. New approaches are needed to more effectively develop highly specific medicines for a wide range of...
2016 - New treatment strategy for obstetric asphyxia and stroke - Marcela Pekna - University of Gothenburg
Brain ischemia, i.e. oxygen deprivation due to lack of blood circulation after stroke or childbirth (asphyxia), is a major cause of...
2016 - New treatment against multidrug-resistant bacteria by activating natural immunity - Peter Bergman - Karolinska Institutet
The aim of the project is to use a cellular model of infection to study the activation of effector mechanisms in the natural immunity,...
